Lipid Profile

Biomarker

Related News

BrightGene Phase III Data for BGM0504 Highlight Multi-Parameter Metabolic Effects

May 12, 2026

BrightGene Bio-Medical reported Phase III data for BGM0504 showing 19.3% mean weight reduction and improvements in blood pressure, lipids and uric acid. The data highlighted GIP as a key variable in broader metabolic management.

Evidence on ketogenic diets remains mixed across mental health, diabetes, and PCOS

Apr 21, 2026

Evidence on ketogenic diets remains limited for psychiatric disorders and diabetes, while a systematic review in overweight and obese women with PCOS found significant short-term improvements. Experts said more controlled, long-term studies are needed.